ArticleHuman vaccines & immunotherapeutics2023

Durability of immune response against omicron BA.2 and BA.4/5 and T cell responses after boosting with mRNA and adenoviral vector-based vaccines following heterologous CoronaVac/ChAdOx-1nCov-19 vaccination.

Nungruthai Suntronwong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.